UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Machine learning in pharmacometrics: Opportunities and challenges

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1482-1499

2022

Volltextzugriff (PDF)

The Delivery of Bad News in Organizations: A Framework for Analysis

Journal of management, 2013-01, Vol.39 (1), p.136-162

Bies, Robert J.

2013

Volltextzugriff (PDF)

Getting Even or Moving On? Power, Procedural Justice, and Types of Offense as Predictors of Revenge, Forgiveness, Reconciliation, and Avoidance in Organizations

Journal of applied psychology, 2006-05, Vol.91 (3), p.653-668

2006

Volltextzugriff (PDF)

Modelling the progression of illicit substance use patterns from real‐world evidence

British journal of clinical pharmacology, 2024-03, Vol.90 (3), p.700-712

2024

Volltextzugriff (PDF)

Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability

CPT: pharmacometrics and systems pharmacology, 2024-06

2024

Volltextzugriff (PDF)

Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis

Pharmacopsychiatry, 2024-03, Vol.57 (2), p.53-60

2024

Volltextzugriff (PDF)

A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance

The Journal of pharmacology and experimental therapeutics, 2022-12, Vol.383 (3), p.217-226

2022

Volltextzugriff (PDF)

Lenient Reactions to Misconduct: Examining the Self-Conscious Process of Being Lenient to Others at Work

Academy of Management journal, 2021-04, Vol.64 (2), p.351-377

2021

Volltextzugriff (PDF)

Considering personal needs in misdeeds: The role of compassion in shaping observer reactions to leader leniency

Journal of applied psychology, 2024-09

2024

Volltextzugriff (PDF)

Evaluation of ChatGPT and Gemini large language models for pharmacometrics with NONMEM

Journal of pharmacokinetics and pharmacodynamics, 2024-06, Vol.51 (3), p.187-197

2024

Volltextzugriff (PDF)

Authors’ response to letter to editor

Journal of pharmacokinetics and pharmacodynamics, 2024-08, Vol.51 (4), p.305-305

2024

Volltextzugriff (PDF)

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine

Pharmaceutics, 2023-04, Vol.15 (4), p.1139

2023

Volltextzugriff (PDF)

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Journal of the American Geriatrics Society (JAGS), 2008-07, Vol.56 (7), p.1333-1341

2008

Volltextzugriff (PDF)

Preface to Special Issue for Panos Macheras

Journal of pharmacokinetics and pharmacodynamics, 2019-04, Vol.46 (2), p.103-103

Bies, Robert R.

2019

Volltextzugriff (PDF)

Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial

Journal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.329-335

2019

Volltextzugriff (PDF)

When Something Is Not Right: The Value of Silence

Academy of Management perspectives, 2019-08, Vol.33 (3), p.323-333

2019

Volltextzugriff (PDF)

Perspectives on the past, present, and future of pharmacometrics

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1403-1405

2022

Volltextzugriff (PDF)

Consumer Privacy: Balancing Economic and Justice Considerations

Journal of social issues, 2003-07, Vol.59 (2), p.323-342

2003

Volltextzugriff (PDF)

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Schizophrenia bulletin, 2013-05, Vol.39 (3), p.564-574

2013

Volltextzugriff (PDF)

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

Clinical and translational science, 2019-09, Vol.12 (5), p.519-528

2019

Volltextzugriff (PDF)

Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study

Schizophrenia bulletin, 2013-09, Vol.39 (5), p.993-998

2013

Volltextzugriff (PDF)

Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model

Clinical pharmacology and therapeutics, 2024-05, Vol.115 (5), p.1162-1174

2024

Volltextzugriff (PDF)

Panos Macheras: a pioneering scientist in pharmaceutical science

Journal of pharmacokinetics and pharmacodynamics, 2019-04, Vol.46 (2), p.105-109

2019

Volltextzugriff (PDF)

Second Acts and Second Chances: The Bumpy Road to Redemption

Journal of management inquiry, 2021-10, Vol.30 (4), p.371-384

2021

Volltextzugriff (PDF)

Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients

British journal of cancer, 2022-03, Vol.126 (4), p.640-651

2022

Volltextzugriff (PDF)

1 – 25 von 280

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(225)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(279)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Life Sciences & Biomedicine
(138)
Humans
(124)
Pharmacology & Pharmacy
(93)
Male
(83)
Female
(80)
Adult
(63)
Middle Aged
(59)
Biological And Medical Sciences
(51)
Aged
(49)
Medical Sciences
(44)
Pharmacokinetics
(42)
Psychiatry
(38)
Social Sciences
(38)
Pharmacology. Drug Treatments
(37)
Models, Biological
(28)
Business & Economics
(24)
Management
(24)
Pharmacology/toxicology
(23)
Psychology. Psychoanalysis. Psychiatry
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Machine learning in pharmacometrics: Opportunities and challenges

The Delivery of Bad News in Organizations: A Framework for Analysis

Getting Even or Moving On? Power, Procedural Justice, and Types of Offense as Predictors of Revenge, Forgiveness, Reconciliation, and Avoidance in Organizations

Modelling the progression of illicit substance use patterns from real‐world evidence

Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability

Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis

A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance

Lenient Reactions to Misconduct: Examining the Self-Conscious Process of Being Lenient to Others at Work

Considering personal needs in misdeeds: The role of compassion in shaping observer reactions to leader leniency

Evaluation of ChatGPT and Gemini large language models for pharmacometrics with NONMEM

Authors’ response to letter to editor

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Preface to Special Issue for Panos Macheras

Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial

When Something Is Not Right: The Value of Silence

Perspectives on the past, present, and future of pharmacometrics

Consumer Privacy: Balancing Economic and Justice Considerations

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study

Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model

Panos Macheras: a pioneering scientist in pharmaceutical science

Second Acts and Second Chances: The Bumpy Road to Redemption

Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients

Suchergebnisse filtern